Identification of a novel antigenic structure of the human receptor for interleukin-6 involved in the interaction with the glycoprotein 130 chain

Immunology

Volumn 89, Issue 1, 1996, Pages 135-141

  Gaillard, J P ^a   Liautard, J ^a   Mani, J C ^b   Fernandez Suarez, J M ^a   Klein, B ^c   Brochier, J ^a  

^a INSERM   (France)

^b UNIV MONTPELLIER   (France)

^c INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; GLYCOPROTEIN GP 130; INTERLEUKIN 6; MONOCLONAL ANTIBODY;

ARTICLE; CELL LINE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MYELOMA CELL; PLASMACYTOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0029790628     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1996.d01-709.x     Document Type: Article

References (38)

1. KISHIMOTO T., AKIRA S. & TAGA T. (1992) Interleukin-6 and its receptor: a paradigm for cytokines. Science 258, 593.
2. MÜLLBERG J., SCHOOLTINK H., STOYAN T. et al. (1993) The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol 23, 473.
3. HORIUCHI S., KOYANAGI Y., ZHOU Y. et al. (1994) Soluble interleukin-6 receptors released from T cell or granulocyte/ macrophage cell lines and human peripheral blood mononuclear cells are generated through alternative splicing mechanism. Eur J Immunol 24, 1945.
4. LUST J.A., DONOVAN K.A., KLINE M.P., GREIPP P.R., KYLE R.A. & MAIHLE N.J. (1992) Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine 4, 96.
5. TAGA T., HIBI M., HIRATA Y. et al. (1989) Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 58, 573.
6. GAILLARD J.P., BATAILLE R., BRAILLY H. et al. (1993) Increased and highly stable levels of functional soluble-interleukin-6 receptor in sera of patients with monoclonal gammopathy. Eur J Immunol 23, 820.
7. ROSE JOHN S. & HEINRICH P.C. (1994) Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J 300, 281.
8. KAWANO M., IRANO T., MATSUDA T. et al. (1988) Autocine generation and requirement of BSF/2/IL-6 for human multiple myeloma. Nature 332, 83.
9. KLEIN B., ZHANG, X.G. JOURDAN M. et al. (1990) Interleukin-6 is the central tumoral growth factor in multiple myeloma. Eur Cytokine Netw 1, 193.
10. BATAILLE R., BARLOGIE B., L Z.Y. et al. (1995) Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma. Blood 86, 685.
11. KLEIN B., WIJDENES J., ZHANG X.G. et al. (1991) Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood 78, 1198.
12. EMILIE D., WIJDENES J., GISSELBRECHT C., et al. (1994) Administration of an anti-interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma. Effect on lymphoma growth and on B clinical symptoms. Blood 84, 2472.
13. MILES S.A., REZAI A.R., SALAZAR GONZALEZ J.F. et al. (1990) Kaposi's sarcoma-derived cells produce and respond to interleukin-6. Proc. Natl. Acad Sci USA 87, 4068.
14. MIKI S., IWANO M., YAMOMOTO M. et al. (1989) Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinoma. FEBS Lett 250, 607.
15. KISHIMOTO T. (1992) Interleukin-6 and its receptor in autoimmunity. J Autoimmunol 5 (suppl A), 123.
16. WENDING D., RACADOT E. & WIJDENES J. (1993) Treatment of severe Rheumatoid Arthritis by anti-interleukin-6 monoclonal antibody. J Rheumatol 20, 259.
17. GRAU G.E., FREI K., PIGUTI P.F. et al. (1990) Interleukin-6 production in experimental cerebral malaria: modulation by anticytokine antibodies and possible role in hypergammaglobulinemia. J Exp Med 172, 1505.
18. LIAUTARD J., GAILLARD J.P., MANI J.C. et al. (1994) Epitope analysis of human IL-6 receptor gp80 molecule with monoclonal antibodies. Eur Cytokine Netw 5, 293.
19. ZHANG X.G., GAILLARD J.P., ROBILLARD N. et al. (1994) Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood 83, 3654.
20. ZHANG X.G., GU J.J., LU Z.Y. et al. (1994) Ciliary neurotrophic factor, interleukin-11, leukemia inhibitor factor and oncostatin M are growth factors for human myeloma cell lines using the interleukin-6 transducer gp130. J Exp Med 177, 1337.
21. MONTIRO-JULIAN F.A., LIAUTARD J., FLAVETTA S. et al. (1994) Immunoassay for functional human soluble interleukin-6 receptor in plasma based on ligand/receptor interaction. J Immunol Methods 169, 111.
22. HIBI M., MURAKAMI M., SAITO M., HIRANO T. & KISHIMOTO T. (199) Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63, 1149.
23. SAITO T., TAGA D., MIKI D. et al. (1993) Preparation of monoclonal antibodies against the IL-6 signal transducer, gp130, that can inhibit IL-6 mediated functions. J Immunol Methods 163, 217.
24. WIJDENES J., CLÉMENT C., KLEIN B. et al. (1991) Human recombinant dimeric IL-6 binds to its receptor as detected by monoclonal antibodies. Mol Immunol 28, 1183.
25. YAWATA H., YASUKAWA K., NATSUKA S. et al. (1993) Structure-function analysis of human IL-6 receptor: dissociation of amino acid residues required for IL-6 binding and for IL-6 signal transduction through gp130. EMBO 12, 1705.
26. FAGERSTAM L.G., FROSTELL A., KARLSSON R., KULLMAN M. & LARSON A. (1990) Detection of antigen antibody interactions by surface plasmon resonance. Application to epitope mapping. J Mol Recogn 3, 208.
27. MALMQUIST M. (1993) Surface plasmon resonance for detection and measurement of antibody antigen affinity and kinetics. Curr Opin Immunol 5, 282.
28. HALIMI H., EISENSTEIN M., OH J.W., REVEL M. & CHEBATH J. (1995) Epitope peptides from interleukin-6 receptor which inhibit the growth of human myeloma cells. Eur Cytokine Netw 6, 135.
29. GAILLARD J.P., LIAUTARD J., DUPERRAY C. & BROCHIER J. (1995) mAb against human gp80 IL-6 receptor. In: Leucocyte Typing V (eds S.F. Schlossman et al.) Vol. 2, p. 1891. Oxford University Press, Oxford.
30. NOVICK D., ENGELMANN H., REVEL M., LETTNER O. & RUBINSTEIN M. (1991) Monoclonal antibodies to the soluble human IL-6 receptor: affinity purification, ELISA and inhibition of ligand binding. Hybridoma 10, 137.
31. LU Z.Y. BRAILLY H., ROSSI J.F., WIJDENES J., BATAILLE R. & KLEIN B. (1993) Overall interleukin-6 production exceeds 7 mg/day in multiple myeloma complicated by sepsis. Cytokine 5, 578.
32. SAVINO R., LAHM A., SALVATI A.L. et al. (1994) Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activation. EMBO 13, 1357.
33. BRAKENHOFF J.P.J., DE HOHN F.D., FONTAINE V. et al. (1994) Development of a human interleukin-6 receptor antagonist. J Biol Chem 269, 86.
34. HONDA M., YAMAMOTO S., CHENG M. et al. (1992) Human soluble IL-6 receptor: its detection and enhanced release in HIV infection. J Immunol 148, 2175.
35. SUZUKI H., YASUKAWA K., SAITO T. et al. (1993) Serum soluble interleukin-6 receptor in MRL/lpr mice is elevated with age and mediates the interleukin-6 signal. Eur J Immunol 23, 1078.
36. MONTERO JULIAN F.A., KLEIN B., GAUTHEROT E. & BRAILLY H. (1995) Pharmacokinetic study of anti-interleukin-6 (IL-6) therapy with monoclonal antibodies: enhancement of IL-6 clearance by cocktails of anti-IL-6 antibodies. Blood 85, 917.
37. TILG H., TREHU E., ATIKINS M.B., DINARELLO C.A. & MIER J.W. (1994) Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83, 113.
38. SALVATI A.L., LAHM A., PAONESSA G., CILIBERTO G. & TONIALLI C. (1995) Interleukin-6 (IL-6) antagonism by soluble IL-6 receptor alpha mutated in the predicted gp130-binding interface. J Biol Chem 270, 12242.